Can a bright lamp lift teen depression? new study tests home light therapy
NCT ID NCT06913309
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a bright light device at home for 40 minutes each morning can help teens aged 13-17 with major depression. Participants are split into three groups: high-intensity light, medium-intensity light, or a dim red light placebo. The goal is to see if light therapy safely reduces depressive symptoms and improves sleep, thinking, and mood over four weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bright light therapy (device)
- What this could lead to
- If it works, this could offer a safe, non-drug option to ease depression symptoms in teens, possibly improving mood and daily function.
- What could go wrong
- This is an early-stage trial with only 168 participants, so results may not apply to all teens. The placebo effect from light exposure could also blur the true benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 168 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
13 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
The inclusion and exclusion criteria for MDD patients: 1. inclusion criteria * Meeting DSM-IV diagnostic criteria for a major depressive episode (first-episode or recurrent) , confirmed by two experienced, independent psychiatrists using the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-Kid); * Aged 13-17 years ; * Medication-naïve or on a stable pharmacological regimen for ≥1 week prior to enrollment; * Baseline Hamilton Depression Rating Scale-17 (HAMD-17) score ≥14; * Minimum of 5 years of formal education, with the ability to complete clinical assessments and comprehend study-related information; * Voluntary participation with written informed consent provided by both participants and their legal guardians. 2. exclusion criteria * Current or past diagnosis of psychiatric disorders other than anxiety or sleep disorders; * History of substance abuse or dependence history (including alcohol, nicotine, or illicit drugs); * Baseline Young Mania Rating Scale (YMRS) total score ≥6; * Received or planned to initiate non-pharmacological systemic interventions within 6 months prior to enrollment or within 1 month after enrollment, including but not limited to: structured psychotherapy (≥1 session/month for \>6 months), physical therapy (e.g., modified electroconvulsive therapy \[MECT\], repetitive transcranial magnetic stimulation \[rTMS\], transcranial direct current stimulation \[tDCS\], or deep brain stimulation \[DBS\]), or exercise therapy ; * Clinician-assessed suicide risk or a HAMD-17 item 3 score ≥3 at the baseline; * Presence of severe systemic or neurological conditions, such as diabetes, hypertension, renal failure, hepatic dysfunction, thyroid disorders, encephalitis, traumatic brain injury, or epilepsy; * Severe retinal pathologies (e.g., retinal detachment, optic atrophy, macular degeneration); or having high myopia (spherical equivalent ≤ -6.00 diopters); * Current use of photosensitizing agents or medications (e.g., chlorpromazine, hypericum extract); * Any other condition deemed inappropriate by the investigators(e.g., cases involving severe sleep phase delays that make morning therapy impossible, or unrecorded photosensitivity). The inclusion and exclusion criteria for Health controls 1. Inclusion criteria * Aged 13-17 years and right-handed; * Minimum of 5 years of formal education, with the ability to complete clinical assessments and comprehend study-related information; * Voluntary participation with written informed consent provided by both participants and their legal guardians. 2. Exclusion criteria * Current or lifetime diagnosis of any psychiatric disorders (e.g., schizophrenia, mood disorders, anxiety disorders) or history of substance/drug abuse or dependence; * First-degree family history of psychiatric disorders; * Presence of severe systemic or neurological disorders, such as diabetes, hypertension, renal failure, hepatic dysfunction, thyroid disorders, encephalitis, traumatic brain injury, or epilepsy; * Any other condition deemed inappropriate by the investigators.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depressive disorder, major are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Beijing Huilongguan Hospital
RECRUITINGBeijing, Beijing Municipality, 10000, China
-
Peking University Sixth Hospital
RECRUITINGBeijing, Beijing Municipality, 10000, China
-
Yan'an Third People's Hospital
RECRUITINGYanan, Shanxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Patients helping patients: a new test for depression care
- Could a new injection keep depression at bay for longer?
- Could a single dose of a new drug boost depression relief?
- Can a new pill ease depression without Add-Ons?
- Brain scans could make TMS for depression more precise
- Can brain training help depressed young adults stop ruminating?